Sionna Therapeutics, Inc. - Common Stock (NQ:SION)

46.50 -0.63 (-1.34%)

Streaming Delayed Price Updated: 10:23 AM EDT, Aug 3, 2026 Add to My Watchlist

Price and Volume

Volume	65,231
Open	46.86
Bid (Size)	46.38 (200)
Ask (Size)	46.64 (200)
Prev. Close	47.13
Today's Range	45.57 - 47.07
52wk Range	16.48 - 51.56
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences

May 27, 2026

From Sionna Therapeutics, Inc.

Via GlobeNewswire

Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

May 13, 2026

From Sionna Therapeutics, Inc.

Via GlobeNewswire

Performance

YTD	+18.6%	+18.6%
1 Month	+7.8%	+7.8%
3 Month	+15.0%	+15.0%
6 Month	+6.5%	+6.5%
1 Year	+171.6%	+171.6%

More News

Sionna Therapeutics Reports First Quarter 2026 Financial Results

May 12, 2026

From Sionna Therapeutics, Inc.

Via GlobeNewswire

Sionna Insider Sells $2.5 Million in Stock Amid 215% Surge, but Here's What Investors Should Watch ↗

April 27, 2026

Via The Motley Fool

Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis

April 27, 2026

From Sionna Therapeutics, Inc.

Via GlobeNewswire

Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium

April 07, 2026

From Sionna Therapeutics, Inc.

Via GlobeNewswire

Sionna Chief Legal Officer Cashed Out Her Shares. Her Options Are Another Story ↗

March 30, 2026

Via The Motley Fool

ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch ↗

March 21, 2026

Via The Motley Fool

Sionna Stock Is Up 144% This Past Year. Is the Biotech a Buy as One Fund Makes a $7 Million Bet? ↗

March 18, 2026

Via The Motley Fool

This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares ↗

March 15, 2026

Via The Motley Fool

Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

March 02, 2026

From Sionna Therapeutics, Inc.

Via GlobeNewswire

Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences

February 23, 2026

From Sionna Therapeutics, Inc.

Via GlobeNewswire

Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026

February 04, 2026

From Sionna Therapeutics, Inc.

Via GlobeNewswire

Sionna Therapeutics Chief Legal Officer Caps Off Strong 2025 with Sale of Over 10,000 Shares ↗

January 12, 2026

Via The Motley Fool

Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 05, 2026

From Sionna Therapeutics, Inc.

Via GlobeNewswire

A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million ↗

January 03, 2026

Via The Motley Fool

Sionna Therapeutics to Participate in Upcoming December Investor Conferences

November 24, 2025

From Sionna Therapeutics, Inc.

Via GlobeNewswire

Sionna Therapeutics Reports Third Quarter 2025 Financial Results

November 05, 2025

From Sionna Therapeutics, Inc.

Via GlobeNewswire

Sionna Therapeutics to Participate in Upcoming November Investor Conferences

November 04, 2025

From Sionna Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 27, 2025

Via Benzinga

Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference

October 24, 2025

From Sionna Therapeutics, Inc.

Via GlobeNewswire

Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis

October 21, 2025

From Sionna Therapeutics, Inc.

Via GlobeNewswire

Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference

October 01, 2025

From Sionna Therapeutics, Inc.

Via GlobeNewswire

Sionna Therapeutics Appoints Caroline Stark Beer as Chief Business Officer

September 08, 2025

From Sionna Therapeutics, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Sionna Therapeutics, Inc. - Common Stock publicly traded?

Yes, Sionna Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Sionna Therapeutics, Inc. - Common Stock trade on?

Sionna Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Sionna Therapeutics, Inc. - Common Stock?

The ticker symbol for Sionna Therapeutics, Inc. - Common Stock is SION on the Nasdaq Stock Market

What is the current price of Sionna Therapeutics, Inc. - Common Stock?

The current price of Sionna Therapeutics, Inc. - Common Stock is 46.50

When was Sionna Therapeutics, Inc. - Common Stock last traded?

The last trade of Sionna Therapeutics, Inc. - Common Stock was at 08/03/26 10:23 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.